top of page
Browse by category
Search
Novo Nordisk completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity
Novo Nordisk has announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and amylin receptor...
No haemodynamic and respiratory differences between reverse Trendelenburg and beach chair positions during LSG
There was no difference between reverse Trendelenburg position (RTP) and beach chair (BC) position during laparoscopic sleeve...
SGLT-2 dapagliflozin plus moderate calorie restriction achieves higher diabetes remission than calorie restriction alone
Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug...
Allurion plans study to optimise muscle mass during GLP-1 therapy in combination with the Allurion Program
Allurion Technologies plans to initiate a clinical study on the combination of the Allurion Program with GLP-1 agonists to improve muscle...
UDCA reduces the need for cholecystectomy in patients with post-LSG gallstones, but ineffective for pre-existing gallstones
Ursodeoxycholic acid (UDCA) is a promising option for reducing the need for cholecystectomy in patients with post-laparoscopic sleeve...
Insurance coverage and type of employment shaping inequities in access to semaglutide
A study by Boston University School of Public Health (BUSPH) researchers has found that disparities in access to semaglutide, with rates...
Browse by tag
bottom of page